HilleVax downgraded to Neutral at JPMorgan after failure of vaccine study
PremiumThe FlyHilleVax downgraded to Neutral at JPMorgan after failure of vaccine study
18d ago
HilleVax downgraded to Neutral from Overweight at JPMorgan
PremiumThe Fly
HilleVax downgraded to Neutral from Overweight at JPMorgan
18d ago
HilleVax downgraded to Neutral from Buy at Guggenheim
PremiumThe Fly
HilleVax downgraded to Neutral from Buy at Guggenheim
18d ago
JPMorgan ups HilleVax target, adds to Analyst Focus List
PremiumThe FlyJPMorgan ups HilleVax target, adds to Analyst Focus List
2M ago
HilleVax reports Q1 EPS (97c), consensus (84c)
PremiumThe Fly
HilleVax reports Q1 EPS (97c), consensus (84c)
3M ago
HilleVax files $500M mixed securities shelf
PremiumThe Fly
HilleVax files $500M mixed securities shelf
4M ago
HilleVax, Inc. Announces Executive Team Restructuring
PremiumMarket NewsHilleVax, Inc. Announces Executive Team Restructuring
6M ago
HilleVax appoints McLoughlin as Chief Operating Officer
PremiumThe Fly
HilleVax appoints McLoughlin as Chief Operating Officer
6M ago
HilleVax Announces Executive Management Appointment of Sean McLoughlin as Chief Operating Officer
PremiumPress Releases
HilleVax Announces Executive Management Appointment of Sean McLoughlin as Chief Operating Officer
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100